Poland – Delivery of the medicinal product Pembrolizumab settled under the B.6 drug program.
By: Institute of Tuberculosis and Lung Diseases📍 PolandOpen
Key Information
| Reference | GB-789313-2026 |
|---|
| Deadline | Dec 15, 2026 12:00 AM |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Poland |
|---|
| Address | streetPłocka 26, Warsaw, 01-138, Poland |
|---|
| Published | Nov 12, 2026 |
|---|
Description
2. Procedure2.1.ProcedureTitle: Delivery of the medicinal product Pembrolizumab settled under the B.6 drug program.Description: The subject of the order is the supply of the medicinal product Pembroli...
Full details are available after unlocking this tender.